7Malik RK, Marisa AM, Mario RR, et al. Epidemiology and control of Vancomycin-resistant Enterococci in a regional neonatal intensive care unit[J]. Pediatr lnfect Dis J, 1999,18(4):352.
8Elsner HA, Sobottka I, Feucht HH, et al. In vivo susceptibilities of enterococccal blood culture isolates from the Hamberg area to ten antibiotics[J]. Chemotherapy, 2000,46:104-110.
9Ma XH, Kudo M, Takahashi A, et al. Evidence of nosocomial infection in Japan caused by high-level genetamicin resistant Enterococci faecalis and identification of the pheromone-responsive conjugative plasmid encoding genetamicin resistance[J]. J Clin Microbiol,1998, 36(9):2460-2464.
10Zervos MJ, Kauffman CA, Therasse PM, et al. Nosocomial Infection by Gentamicin-Resistant Streptococcus faecalis[J]. Ann Intern Med, 1987,106(5) :687-691.
7Garazzino S,De Rosa FG,Bargiacchi O, et al.Haemato-logical safety of long-term therapy with linezolid[J]. Int JAntimicrob Agents ,2007,29(4): 480.
8McCollum M,Sorensen SV,Liu LZ,et al.A comparisonof costs and hospital length of stay assoctiated with intra-venous/oral linezolid or intravenous vancomycin treat-ment of complicated skin and sofl-tissue infections causedby suspected or confirmed methicillin-resistant staphylo-coccus aureus in elderly US patients[J].C//? Ther, 2007,29(3):469.
9Gomez-Gil R, Romero-Gomez MP, Garcia-Arias A,et al. Nosoco-mial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital[J].Diagn Microbiol Infect Dis,2009,65(2): 175-179.
